Ania Jastreboff, who led the Phase 2 retatrutide trial at Yale, noted in a 2023 interview with STAT News: "The science is moving faster than the access infrastructure
Glucagon-like peptide 1 (GLP-1) controls insulin release from the pancreas, which in turn controls glucose homeostasis
Your liver produces glutathione naturally, and every cell in your body contains it
Epics prior authorization module, for example, allows smart routing: if the insurance is connected to the ePA network, the form routes automatically
The trial team is the right source for information about screening, visits, study medication, and participant responsibilities